SPINK1, which is highly expressed in prostate cancer, is transcriptionally inhibited by AR and its corepressor, REST, while AR antagonists alleviate this inhibition and lead to upregulation of SPINK1. The gene discussed is AR; the disease is Familial prostate cancer.